FREE SHIPPING ON ORDERS OVER $150

kras mutation and glutathion Targeting Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell KRAS | OriGene Technologies Inc.

$29.02

Quantity
- +
Description

Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-B signaling

kras mutation and glutathion Targeting Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell KRAS | OriGene Technologies Inc.

VNS decreases cardiac mitochondrial ROS production, prevents mitochondrial membrane depolarization and swelling, improves mitochondrial biogenesis and dynamics (increased mitochondrial fusion and decreased mitochondrial fission), shifts cardiac fatty acid metabolism toward betaoxidation, increases levels of cardiac mitochondrial complexes and inhibits the opening of mitochondrial permeability transition in pig (Shinlapawittayatorn et al

kras mutation and glutathion Targeting Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell KRAS | OriGene Technologies Inc.

Corcelle-Termeau et al

kras mutation and glutathion Targeting Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell KRAS | OriGene Technologies Inc.

and high, H-GSH: N=11) based on a median split

kras mutation and glutathion Targeting Mutant Cancers with a Covalent G12C-Specific Inhibitor: Cell KRAS | OriGene Technologies Inc.

You may also like

CJC 1295

US$ 23.61

4.5 (13 reviews)

recommand products